Alaa Meshref

748 citations
25 papers · 574 indexed · h-index 13

Alaa Meshref

22 papers receiving 546 citations

Peers

Alaa Meshref
Comparison fields: 5 of 50
  • Urology 108
  • Pulmonary and Respiratory Medicine 471
  • Rheumatology 180
  • Cancer Research 53
  • Obstetrics and Gynecology 23
Replace P. Carpentier with:
P. Carpentier Netherlands
Nachiketh Soodana‐Prakash United States
H. P. Van Poppel Belgium
M. Kurosch Germany
Ioannis Zachos Greece
Valerio Vagnoni Italy
Angelica Grasso Italy
Hideshige Koh Japan
Mohammed Haseebuddin United States
Jeroen van Moorselaar Netherlands
Alaa Meshref relative to P. Carpentier Netherlands P. Carpentier's profile →
Citations per field
00.5×
P. Carpentier · 1×
Citations per year

Countries citing papers authored by Alaa Meshref

Since Specialization
Citations

This map shows the geographic impact of Alaa Meshref's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Meshref with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Meshref more than expected).

Fields of papers citing papers by Alaa Meshref

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Meshref. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Meshref. The network helps show where Alaa Meshref may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alaa Meshref, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alaa Meshref Line = papers co-authored together Alaa Meshref links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20233
3 20230
4 202113
5 201433
6 201325
7 20126
8 201177
9 201018
10 201078
11 20071
12 20073
13 200615
14 19985
15 199625
16 199523
17 199553
18 199540
19 1994135
20 199214

About Alaa Meshref

Alaa Meshref is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 25 papers that have together received 574 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (15 papers), Urinary Bladder and Prostate Research (9 papers), Prostate Cancer Treatment and Research (6 papers), Urologic and reproductive health conditions (5 papers), Ureteral procedures and complications (3 papers), Kidney Stones and Urolithiasis Treatments (3 papers), Pediatric Urology and Nephrology Studies (3 papers) and Urological Disorders and Treatments (2 papers). The work is most often cited by research in Urology (108 citations), Pulmonary and Respiratory Medicine (471 citations) and Rheumatology (180 citations). Alaa Meshref has collaborated with scholars based in Egypt, Canada and Türkiye. Frequent co-authors include Michel Bazinet, Mostafa Elhilali, Samuel Aronson, Claude Trudel, Mahmoud Nachabé, François Péloquin, Louis R. Bégin, Ashraf Mosharafa, Armen Aprikian and Jean Dessureault. Their work appears in journals such as Urology, The Journal of Urology, World Journal of Urology, Journal of Endourology and International Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026